Cyanidin-3-O-Glucoside Alleviates Hepatic Steatosis and Inflammation in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice via the AMPK/SIRT1/NF-κB Pathway
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27114698 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Xiping Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Life Sciences, Jilin Normal University, Siping 136000, China. Hauptthemen laut MEDLINE: Anthocyanins, Non-alcoholic Fatty Liver Disease, NF-kappa B, Glucosides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Science and Technology Department.
Abstract (Originalsprache)
Cyanidin-3-O-Glucoside (C3G) is the primary anthocyanin-active component in bilberry, exhibiting various pharmacological activities such as antioxidant, anti-inflammatory, and lipid metabolism-regulating effects. To address the clinical need for non-alcoholic fatty liver disease (NAFLD) prevention and treatment, this study aimed to investigate the ameliorative effects of C3G on NAFLD pathology and elucidate its molecular mechanisms of protection via the AMPK pathway. After a one-week acclimatization period, 20 six-week-old SPF mice were randomly divided into four groups: normal diet control (NCD), high-fat diet model (HFD), HFD + L-C3G (100 mg/kg/day), and HFD + H-C3G (200 mg/kg/day). Except for the NCD group, the remaining groups were fed a 60% high-fat diet for four weeks to establish an early-stage NAFLD model, with successful model construction verified by weight and liver weight gain. From the fifth week onward, C3G groups received daily administration for four consecutive weeks, while control groups were given an equal volume of distilled water. Liver function, lipid metabolism, oxidative stress, and inflammatory levels were assessed using ELISA, H&E staining, and other methods. The results showed that C3G restored liver function in NAFLD mice, improved lipid metabolism disorders, reduced oxidative stress and inflammatory responses, and alleviated liver pathological damage. Mechanistic studies revealed that C3G regulated the expression of mRNA and proteins related to the AMPK/SIRT1/NF-κB signaling pathway, activating the pathway by upregulating AMPK and its upstream regulators while inhibiting NF-κB-mediated inflammatory responses. This study confirmed that C3G can ameliorate high-fat diet-induced NAFLD lesions by activating the AMPK/SIRT1/NF-κB pathway, providing a potential intervention strategy for NAFLD prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, College of Life Sciences, Jilin Normal University, Siping 136000, China.
- Development and Utilization of Wild Plant Resources in Changbai Mountain, Boda College, Jilin Normal University, Siping 136000, China.
ORCID-Profile: Yi Yang
Förderung
- Jilin Province Science and Technology Department
Zitieren
APA
Liu, X., Li, W., Xu, X., Wang, J., Liu, Y., Ma, Y., Su, X., Shen, X., & Yang, Y. (2026). Cyanidin-3-O-Glucoside Alleviates Hepatic Steatosis and Inflammation in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice via the AMPK/SIRT1/NF-κB Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27114698
Vancouver
Liu X, Li W, Xu X, Wang J, Liu Y, Ma Y, et al. Cyanidin-3-O-Glucoside Alleviates Hepatic Steatosis and Inflammation in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice via the AMPK/SIRT1/NF-κB Pathway. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27114698
BibTeX
@article{Liu2026,
author = {Liu, Xiping and Li, Wenya and Xu, Xiang and Wang, Jichun and Liu, Yuhang and Ma, Yuxi and Su, Xin and Shen, Xiaoxi and Yang, Yi},
title = {Cyanidin-3-O-Glucoside Alleviates Hepatic Steatosis and Inflammation in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice via the AMPK/SIRT1/NF-κB Pathway},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27114698}
}
EUVIMED